Inventor
Iwao Ojima
Inventor
Port Jefferson, NY, US
Overview
Patents· 41 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
Y02PClimate change mitigation technologies in the production or processing of goods6%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C07BGeneral methods of organic chemistry3%
C07KPeptides3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
11,040,947Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors202111,026,910a- and g-truxillic acid derivatives and pharmaceutical compositions thereof202110,968,163Alpha-truxillic acid derivatives and pharmaceutical compositions thereof202110,550,093Third generation taxoids and methods of using same202010,280,183Therapeutic agent for treating tumors201910,213,406a- and g-truxillic acid derivatives and pharmaceutical compositions thereof201910,206,875Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells201910,029,014Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery20189,845,296Benzimidazoles and their use in the treatment of tuberculosis20179,675,576'Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances'20179,604,904'Alpha- and gamma-truxillic acid derivatives and pharmaceutical compositions thereof'20179,220,695'Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances'20158,232,410'Benzimidazoles and pharmaceutical compositions thereof'20127,981,926'Fluorotaxoids'20117,847,119'Drug conjugates'20107,820,839'Taxoid-fatty acid conjugates and pharmaceutical compositions thereof'20107,615,653'Anti-tuberculosis taxane compounds'20097,282,590'Drug conjugates'20076,835,746'Taxoid anti-tumor agents and pharmaceutical compositions thereof'20046,593,482'Methods for preparing new taxoids and pharmaceutical compositions containing them'20036,500,858'Taxoid anti-tumor agents and pharmaceutical compositions thereof'20026,458,976'Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods'20026,218,553'Process for the preparation of taxane derivatives and .beta.-lactam intermediates therefor'20016,187,916'Process for the preparation of taxane derivatives and .beta.-lactam intermediates therefor'20016,100,411'Taxoid anti-tumor agents and pharmaceutical compositions thereof'20006,096,909'Taxoid anti-tumor agents and pharmaceutical compositions thereof'20005,962,744'Process for hydrocarbonylations in supercritical carbon dioxide'19995,811,452'Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof'19985,705,508'Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment'19985,599,820'Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment'19975,475,011'Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment'19955,338,725'Anti-aggregatory agents for platelets'19945,294,737'Process for the production of chiral hydroxy-.beta.-lactams and hydroxyamino acids derived therefrom'19945,276,137'Analgesic peptides with a trifluoronorvaline modification'19945,017,718'Process for preparing polyfluoroalkyl-substituted compounds'19914,621,150'Catalyst and method for isomerization'19864,609,715'Copolymer of fluoromethacrylate with styrene or its derivative and method of preparing same'19864,540,835'Preparation of 2-trifluoromethylpropanol by vapor phase hydrogenation of 2-trifluoromethylpropanal'19854,497,964'Process for production of N-acyl-.alpha.-amino acids'19854,370,504'Process for producing perfluorocarbon group-containing aldehydes'19834,352,752'Process for the preparation of dipeptides'1982Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1982–1991Patents assigned to SAGAMI CHEM RES (6)· patent assignee history
1982–1985Based in Sagamihara, JP· patent location history
1985–1986Based in East Setauket, NY, US· patent location history
1986–2001Based in Stony Brook, NY, US· patent location history
1991Based in New York, NY, US· patent location history
1994–2021Patents assigned to UNIV NEW YORK STATE RES FOUND (32)· patent assignee history
1995–1998Patents assigned to INDENA SPA (3)· patent assignee history
2001–2021Based in Port Jefferson, NY, US· patent location history
2012–2019Patents assigned to OJIMA IWAO (4)· patent assignee history
2017–2019Patents assigned to BALIUS TRENT E (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV NEW YORK STATE RES FOUND | 32 | 1994–2021 |
| SAGAMI CHEM RES | 6 | 1982–1991 |
| OJIMA IWAOself | 4 | 2012–2019 |
| INDENA SPA | 3 | 1995–1998 |
| BALIUS TRENT E | 2 | 2017–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Port Jefferson, New York, US | 23 | 2001–2021 |
| Stony Brook, New York, US | 12 | 1986–2001 |
| Sagamihara, JP | 3 | 1982–1985 |
| East Setauket, New York, US | 2 | 1985–1986 |
| New York, New York, US | 1 | 1991 |